Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02681822
Other study ID # 81425013
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date November 2015
Est. completion date December 2020

Study information

Verified date April 2019
Source Tianjin Medical University General Hospital
Contact Chunshui Yu, PhD
Email chunshuiyu@vip.163.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To study the impact of genetic and environmental factors on high-level cognition associated neural circuits among healthy young Chinese Han subjects.


Description:

The investigators plan to collect behavioral assessment and environmental factors data,peripheral blood sample, MRI brain images in more than 10,000 healthy young Chinese Han individuals in order to build the pathway from gene to high-level cognitive phenotypes.


Recruitment information / eligibility

Status Recruiting
Enrollment 10000
Est. completion date December 2020
Est. primary completion date December 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 30 Years
Eligibility Inclusion Criteria:

- aged 18-30

- Chinese Han

- right-handed

- without history of neuropsychiatric disease

- no substance addiction

- smoking

Exclusion Criteria:

- younger or elder than 18-30 year-old

- other ethnics

- with history of neuropsychiatric disease

- with history of neuropsychiatric disease among first,second and third degree relatives

Study Design


Locations

Country Name City State
China Tianjin Medical University General Hospital Tianjin Tianjin

Sponsors (52)

Lead Sponsor Collaborator
Tianjin Medical University General Hospital Beijing Hospital, Beijing Normal University, Beijing Tongren Hospital, Central South University, Chinese Academy of Science Institute of Automation, Chinese PLA General Hospital, First Affiliated Hospital of Chongqing Medical University, First Affiliated Hospital of Wenzhou Medical University, First Affiliated Hospital Xi'an Jiaotong University, First Hospital of Jilin University, Guangdong General Hospital, Guangdong No.2 Provincial People's Hospital, Henan Provincial Hospital, Huashan Hospital, Inner Mongolia Medical College Hospital, LanZhou University, Nanjing PLA General Hospital, Peking Union Medical College Hospital, Pingjin Hospital,Logistics University of Chinese People's Armed Police Forces, Qilu Hospital of Shandong University, RenJi Hospital, School of Medical Imaging, Tianjin Medical University, Second Affiliated Hospital of Wenzhou Medical University, Second Affiliated Hospital, School of Medicine, Zhejiang University, Shan dong Medical Imaging Research Institute, South China Normal University?Hainan General Hospital, Southwest Hospital, China, Tang-Du Hospital, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, The First Affiliated Hospital of Anhui Medical University, The First Affiliated Hospital of Dalian Medical University, The First Affiliated Hospital of Shanxi Medical University, The First Affiliated Hospital of Zhengzhou University, The First Affiliated Hospital with Nanjing Medical University, The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine, The Frist Hospital Of China Medical University, The Second Hospital of Hebei Medical University, The University of Science and Technology of China, Tianjin First Central Hospital, Tianjin Huanhu Hospital, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University Second Hospital, Tongji Hospital, University of Electronic Science and Technology of China, West China Hospital, Wuhan University, Xiangya Hospital of Central South University, Xijing Hospital, Xuanwu Hospital, Beijing, Xuzhou Medical University, Yantai Yuhuangding Hospital

Country where clinical trial is conducted

China, 

References & Publications (2)

Braskie MN, Jahanshad N, Stein JL, Barysheva M, McMahon KL, de Zubicaray GI, Martin NG, Wright MJ, Ringman JM, Toga AW, Thompson PM. Common Alzheimer's disease risk variant within the CLU gene affects white matter microstructure in young adults. J Neurosci. 2011 May 4;31(18):6764-70. doi: 10.1523/JNEUROSCI.5794-10.2011. — View Citation

Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993 Aug 13;261(5123):921-3. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Brain structure and function measured by MRI scans The participants will receive non-interventional multi-modal MRI scans, such as 3D-T1WI, DTI, DKI, ASL, REST-fmri, then the investigators can acquire the brain volume in region of interest, such as bilateral hippocampus. 2 years
Secondary Childhood adversities as assessed by Childhood Trauma Questionnaire-Short Form (Chinese Version) To investigate impact of the adversities in early life of participants on brain structure and function as well as the interaction effect of childhood adversities and genetic variations,such as 5-HTTLPR polymorphism. 2 years
See also
  Status Clinical Trial Phase
Recruiting NCT05039489 - A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia N/A
Completed NCT05111548 - Brain Stimulation and Cognitive Training - Efficacy N/A
Completed NCT05321602 - Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder Phase 1
Completed NCT04503954 - Efficacy of Chronic Disease Self-management Program in People With Schizophrenia N/A
Completed NCT02831231 - Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium Phase 1
Completed NCT05517460 - The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center N/A
Completed NCT03652974 - Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy Phase 4
Recruiting NCT04012684 - rTMS on Mismatch Negativity of Schizophrenia N/A
Recruiting NCT04481217 - Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia N/A
Completed NCT00212784 - Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935) Phase 3
Completed NCT04092686 - A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia Phase 3
Completed NCT01914393 - Pediatric Open-Label Extension Study Phase 3
Recruiting NCT03790345 - Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics Phase 2/Phase 3
Recruiting NCT05956327 - Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training N/A
Terminated NCT03209778 - Involuntary Memories Investigation in Schizophrenia N/A
Terminated NCT03261817 - A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders N/A
Completed NCT02905604 - Magnetic Stimulation of the Brain in Schizophrenia or Depression N/A
Recruiting NCT05542212 - Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia N/A
Completed NCT04411979 - Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia N/A
Terminated NCT03220438 - TMS Enhancement of Visual Plasticity in Schizophrenia N/A